SweetBio
Growth stage biomedical company in the wound care space with a novel approach and disruptive go-to-market strategy.
The Project
SweetBio, a medical device company, needed support to narrow its focus, define its value proposition, and build a clear investor and commercial strategy. The company sought guidance to strengthen its market position, attract investment, and prepare for scalable growth.
The Solution
Factor 7 developed a compelling investor story, including updates to the pitch deck, summaries, and supporting documents, while leveraging its investor network to facilitate Series A funding introductions. The team also created a comprehensive commercial strategy and roadmap, advising on positioning, branding, and business model enhancements. Additionally, Factor 7 assisted with recruiting and onboarding the company’s first direct sales reps, providing training, oversight, and support to strengthen sales execution.
The Results
With Factor 7’s guidance, SweetBio identified and addressed gaps in its messaging and launch strategy, clarified product positioning, and streamlined its sales process. A pilot program in the Boston market successfully generated new revenue-producing customers. The company also secured sales resources for geographic expansion and established strategic partnerships and distributor agreements to build sustainable, long-term growth.
Services implemented:
Fractional Leadership
Operations
Sales & Marketing
“An invaluable partner whose expertise has helped us shape an exceptional commercial roadmap, and whose network has accelerated pathways for our growth. Factor7 is a true extension of our team.”
Kayla Graff
CEO, SweetBio